Citius Pharmaceuticals
CTXR
CTXR
73 hedge funds and large institutions have $87.4M invested in Citius Pharmaceuticals in 2021 Q2 according to their latest regulatory filings, with 43 funds opening new positions, 18 increasing their positions, 6 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
87% more funds holding
Funds holding: 39 → 73 (+34)
0.42% more ownership
Funds ownership: 0.33% → 0.74% (+0.42%)
Holders
73
Holding in Top 10
–
Calls
$295K
Puts
$116K
Top Buyers
| 1 | +$21.6M | |
| 2 | +$6.85M | |
| 3 | +$3.75M | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$3.66M |
| 5 |
Renaissance Technologies
New York
|
+$3.16M |
Top Sellers
| 1 | -$559K | |
| 2 | -$299K | |
| 3 | -$229K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$139K |
| 5 |
Marshall Wace
London,
United Kingdom
|
-$123K |